Related Experiment Video
Updated: Jun 1, 2026
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Recent advances in molecular diagnosis of thyroid cancer
Ioannis Legakis1, Konstantinos Syrigos
1Department of Endocrinology and Metabolism, Henry Dunant Hospital, Thision, 11851 Athens, Greece.
Abstract:
Recent molecular studies have described a number of abnormalities associated with the progression and dedifferentiation of thyroid carcinoma. These distinct molecular events are often associated with specific stages of tumor development. In particular, remarkable advances have occurred in several major biological areas of thyroid cancer, including the molecular alterations for the loss of radioiodine avidity of thyroid cancer, the pathogenic role of the MAP kinase and PI3K/Akt pathways and their related genetic alterations, and the aberrant methylation of functionally important genes in thyroid tumorigenesis and pathogenesis. Recognition of these features is crucial to the management of patients with thyroid cancer. Novel treatments are being designed based on our enhanced understanding of this disease process.
Insights
Thyroid carcinoma progression involves molecular abnormalities. Understanding these genetic and methylation changes is key for new treatments.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Thyroid carcinoma progression and dedifferentiation are linked to molecular abnormalities.
- Specific molecular events correlate with distinct tumor development stages.
Purpose of the Study:
- To review key molecular alterations in thyroid cancer progression.
- To highlight advances in understanding radioiodine avidity loss, signaling pathways, and gene methylation.
Main Methods:
- Literature review of recent molecular studies on thyroid carcinoma.
- Analysis of molecular events in tumor progression and pathogenesis.
Main Results:
- Identified molecular alterations associated with thyroid cancer progression and dedifferentiation.
- Detailed advances in understanding loss of radioiodine avidity.
- Elucidated the role of MAP kinase and PI3K/Akt pathways and their genetic alterations.
- Described aberrant gene methylation in thyroid tumorigenesis.
Conclusions:
- Recognition of these molecular features is crucial for patient management.
- Enhanced understanding of thyroid cancer pathogenesis is driving novel treatment development.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...